News Releases

1 ... 37 38 39 40

October 12, 2015

From The President’s Desk

Since the beginning of our journey as Atlantic Canada’s Original Licensed Producer, we have made tremendous progress in moving forward with our vision, consistently meeting the high demand for our...
September 2, 2015

OrganiGram Announces The Approval Of Four Additional Grow Rooms

Moncton, N.B. September 02, 2015 – OrganiGram Holdings Inc. (TSX-V: OGI) (OTC US:OGRMF) (the “Company”) is pleased to announce that the Company recently received regulatory approval to activate four more...
August 11, 2015

CEOCFO Magazine Interviews OrganiGram President Mr. Rogers

Interview conducted by:
August 6, 2015

Overview of Medical Marijuana Terminology

Cannabis Cannabis is a plant genus that produces three species of flowering plants: Cannabis sativa, Cannabis indica, and Cannabis ruderalis.
August 6, 2015

Using Medical Marijuana For The First Time

Medical marijuana refers to the dried flowers of the Cannabis plant, containing over 80 different cannabinoids along with terpenes and flavonoids.

1 ... 37 38 39 40

Have a question for us?

Call 1-844-644-4726 (1-844-OGI-GRAM) and the folks on our client support team like Dan, Janice and Jeff can answer any question you have.

Monday to Thursday: 8:30 AM to 8:00 PM 
Friday: 8:30 AM to 6:30 PM 
Fax: 1-855-267-1386

Stay informed. #DiscoverOGI.

Interested in keeping up with Organigram news? Subscribe to our mailing lists and stay up-to-date on Organigram products, patient programs, company news and investor relations. 

By signing up, I acknowledge that I can unsubscribe at any time, and I accept the terms, conditions and privacy policy.

If you wish to receive newsletters from Organigram Holdings Inc. and its subsidiaries, please provide your email address and click on the “Subscribe” button above. If we do not receive your consent, we may be unable to send you communications. If you have any questions, or if you wish to withdraw your consent at any time, please feel free to contact us by phone at 1-844-644-4726 or by email at By clicking “Subscribe” I consent to receipt of communications as indicated above.